Eric Rowinsky, MD (Chairman of the SAB)
Senior VP and Chief Medical Officer at ImClone Systems, Inc.
Key role in development of: Taxol® and Hycamtin®.

Esteban Cvitkovic, MD
Key role in development of: Eloxatin™, Taxotere® and Camptosar®.

Ronald P. McCaffrey, MD
Harvard Medical School
Massachusetts General Hospital

Randall K. Johnson, PhD
Expert in Translational Research
Senior positions at Glaxo-Smith Kline and the National Cancer Institute

Pedro Santabarbara, MD, PhD
VP Strategic Development and Medical Affairs at PHARMA MAR S.A.
Key role in development of: Taxol®;, Taxotere®, Campath®; and Tarceva®.

Allan M. Green, MD, PhD, JD
Expert in FDA regulatory matters and business strategy
Advisor to pharmaceutical industry